Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Chengfu Guan"'
Autor:
Wenlin Xu, Xinhai Huang, Qiwang Lin, Tingting Wu, Chengfu Guan, Meina Lv, Wei Hu, Hengfen Dai, Pei Chen, Meijuan Li, Feilong Zhang, Jinhua Zhang
Publikováno v:
BMC Medical Informatics and Decision Making, Vol 24, Iss 1, Pp 1-12 (2024)
Abstract Background In recent years, mobile medical technology has made great progress in chronic disease management, but its application in patients with atrial fibrillation (AF) still needs to be clarified. Objective This study aims to determine wh
Externí odkaz:
https://doaj.org/article/dd56b2af389345c991d371fe593e3190
Publikováno v:
Global Health Action, Vol 16, Iss 1 (2023)
Background Rheumatic heart disease (RHD) is a serious global public health problem. Objectives This study aims to characterise the regional burden, trends, and inequalities of RHD in countries and territories in the Asian Region. Methods The RHD dise
Externí odkaz:
https://doaj.org/article/0ee88f8469bf405897ade5bb3783f98e
Autor:
Shuyi Wu, Chengfu Guan, Wenlin Xu, Feilong Zhang, Nianxu Huang, Xia Chen, Wang Zhang, Wei Hu, Jun Su, Hengfen Dai, Ping Gu, Xiaohong Huang, Xiaoming Du, Ruijuan Li, Qiaowei Zheng, Xiangsheng Lin, Yanxia Zhang, Lang Zou, Yuxin Liu, Min Zhang, Xiumei Liu, Zhu Zhu, Jianjun Sun, Shanshan Hong, Weibin She, Jinhua Zhang
Publikováno v:
Thrombosis Journal, Vol 21, Iss 1, Pp 1-9 (2023)
Abstract Background Based on the few available studies on the prognostic benefit of using direct oral anticoagulants (DOACs) after atrial fibrillation (AF) ablation. Therefore, this study aimed to evaluate the prognostic differences between patients
Externí odkaz:
https://doaj.org/article/fbdd883f0ada45638d752e38c564668a
Publikováno v:
BMJ Open, Vol 13, Iss 5 (2023)
Objectives An up-to-date, detailed global analysis of the current status of the metabolic-attributed cardiovascular disease (CVD) burden has not been reported. Therefore, we investigated the global burden of metabolic-attributed CVD and its associati
Externí odkaz:
https://doaj.org/article/f71b1453a45548349a5712cf4a0cbb92
Autor:
Chengfu Guan, Wenlin Xu, Meina Lv, Tingting Wu, Xia Chen, Wang Zhang, Nianxu Huang, Hengfen Dai, Ping Gu, Xiaohong Huang, Xiaoming Du, Ruijuan Li, Qiaowei Zheng, Xiangsheng Lin, Yuxin Liu, Min Zhang, Xiumei Liu, Zhu Zhu, Jinhua Zhang
Publikováno v:
The Journal of Clinical Pharmacology.
Publikováno v:
BMJ Open. 13:e069397
ObjectivesAn up-to-date, detailed global analysis of the current status of the metabolic-attributed cardiovascular disease (CVD) burden has not been reported. Therefore, we investigated the global burden of metabolic-attributed CVD and its associatio
Autor:
Shuyi Wu, Meina Lv, Jiana Chen, Shaojun Jiang, Mingrong Chen, Zongwei Fang, Zhiwei Zeng, Jiafen Qian, Wenlin Xu, Chengfu Guan, Jinhua Zhang
Publikováno v:
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 30(12)
The efficacy and safety of direct oral anticoagulants (DOACs), including dabigatran, apixaban, rivaroxaban, and edoxaban, for preventing and treating venous thromboembolism (VTE) in patients with cancer is unclear.We searched the PubMed, Embase, Web